Champions Oncology
Hackensack, NJ, United States championsoncology.com
From their website, Nov 2026
Work here? Claim this listing
About
Champions Oncology is a preclinical oncology CRO providing patient-derived models, ex vivo and in vivo studies, and multi-omic data services for drug developers and researchers. It serves oncology programs across solid tumors, hematologic malignancies, CDX and PDX models, with operations in Hackensack, New Jersey; Rockville, Maryland; and Rehovot, Israel. The company also supports global studies through scientific consultation, model selection, and analytical readouts.
Services
Solid Tumor PDX Models
Provides patient-derived xenograft models for solid tumor oncology research with clinical annotation and multi-omic characterization.
Blood Cancer Models
Offers hematological tumor and leukemia xenograft models including AML, ALL, CLL, lymphoma, and multiple myeloma for preclinical testing.
Pretreated PDX Models
Provides PDX models from pretreated patients to study resistance mechanisms, next-line therapies, and clinical translation.
CDX Models
Offers cell line-derived xenograft models for proof-of-concept, target validation, resistance studies, and biomarker work.
PDX Model Bank
Maintains a searchable bank of patient-derived tumor models for selecting models by tumor indication, modality, or molecular profile.
CDX Model Bank
Provides a filtered bank of CDX models for selection by tumor indication, genetic profile, and gene expression.
TumorGraft3D Ex Vivo Platform
Supports selected ex vivo studies using low-passage, PDX-derived 3D tumor models for cohort comparison and translational questions.
Assays & in vitro testing
Hematological VitroScreen
Runs ex vivo hematologic assays to test therapeutics in blood cancer models.
Assays & in vitro testing
Ex Vivo Solid Tumor Screening
Uses PDX-derived ex vivo solid tumor models for therapeutic screening and comparative studies.
Assays & in vitro testing
In Vivo Preclinical Mouse Models
Conducts preclinical in vivo studies in clinically annotated mouse models for oncology programs.
In Vivo Screening (Mouse Clinical Trials)
Performs in vivo screening studies in mouse models for oncology drug evaluation.
Matched Multi-Omic Dataset
Provides matched genomic, proteomic, clinical, and response data from patient-derived tumor models as a licensed dataset or analysis package.
Genomics & sequencing
Lumin Data Platform
Offers browsable molecular, treatment-history, and prior-response records for PDX and CDX model selection.
Genomics & sequencing
Cell Surface Proteomics Dataset
Provides matched whole-cell and cell-surface proteomics from patient-derived tumor models for target discovery and validation.
Genomics & sequencing
KRAS-Mutant Atlas
Provides a reference atlas comparing KRAS-mutant models under daraxonrasib and optional comparator arms.
Assays & in vitro testing
Radiopharmaceutical Services
Supports radiochemistry and in-house SPECT/CT imaging for radiopharma programs.
Analytical Assays
Offers analytical readouts including flow cytometry, histology/IHC, ELISA/Luminex, next-generation sequencing, proteomics, western blot, DNA damage assays, CFU assay, imaging, cell viability/proliferation, and qPCR.
Assays & in vitro testing
Co-Culture Assays
Runs co-culture assays as part of ex vivo and analytical oncology workflows.
Assays & in vitro testing
Ex Vivo Hematological Cancer Screen
Runs ex vivo screening for hematological cancers to evaluate therapeutic responses outside the animal model.
Assays & in vitro testing
Flow Cytometry
Provides flow cytometry-based analytical services for oncology studies.
Assays & in vitro testing
Histology / IHC
Offers histology and immunohistochemistry analysis for tumor characterization and study readouts.
Assays & in vitro testing
ELISA / Luminex
Performs ELISA and Luminex assays for biomarker and protein measurement.
Assays & in vitro testing
Next Generation Sequencing
Provides NGS-based molecular analysis for characterizing models and study samples.
Genomics & sequencing
4D Proteomics
Offers proteomics analysis to support molecular characterization and biomarker discovery.
Assays & in vitro testing
Western Blot
Performs Western blot analysis for protein detection and validation.
Assays & in vitro testing
DNA Damage Assays
Runs assays to measure DNA damage responses in oncology models.
Assays & in vitro testing
Colony Forming Unit (CFU) Assay
Provides CFU assays for hematological and functional cellular readouts.
Assays & in vitro testing
Imaging
Offers imaging services for preclinical oncology studies, including longitudinal SPECT/CT imaging for radiopharmaceuticals.
Assays & in vitro testing
Cell Viability & Proliferation
Measures cell viability and proliferation as study readouts in oncology models.
Assays & in vitro testing
Quantitative PCR
Provides qPCR for nucleic acid-based measurement and analysis.
Assays & in vitro testing
- Turnaround
- Within 24 hours · Within one business day
- What to send
- Leukapheresis · Peripheral blood · Bone marrow aspirates · Biopsies of patients with advanced-stage disease
Capabilities
- Assays and studies
- In vivo · Rodent models · Flow cytometry · NGS · ADCs · ELISA · Antibodies · Histology · IHC · Luminex · Next generation sequencing · 4D proteomics
11 more
Western blot · DNA damage assays · Colony forming unit (CFU) assay · Imaging · Cell viability · Proliferation · Quantitative PCR · Co-culture assays · Proteomics · Phospho-proteomics · CFU assay - Scale and capacity
- Over 1,500 patient-derived models · Over 1,400 patient-derived models · 700+ pretreated PDX models · 600+ cell-surface profiled models · 300+ TumorGraft3D models · 1,615 RNA-Seq models · 1,599 whole-exome models · 1,006 whole-cell protein models · 607 surface proteomics models · Over 1,500 highly characterized PDX models · 700+ pretreated models · Over 100 cell-line derived xenograft mouse models
1 more
35,000 sq. ft. Rockville, MD research facility - Therapeutic areas
- Oncology · Solid tumors · Hematologic malignancies · Bladder cancer · Prostate cancer · Kidney cancer · Melanoma · Skin cancer · Breast cancer · Colorectal cancer · Leukemia · Lymphoma
1 more
Multiple myeloma
Instruments and platforms
- SPECT/CT
- LC-MS
- IVIS
Modalities and species
- Modalities
- Small molecule · Antibody · Bispecific · ADC · Cell therapy
- Species and models
- Human · Mouse · Patient-derived xenograft (PDX) · Cell line-derived xenograft (CDX) · Acute myeloid leukemia (AML) · Acute lymphoblastic leukemia (ALL) · Chronic lymphoblastic leukemia (CLL) · Diffuse large B-cell lymphoma (DLBCL) · Mantle cell lymphoma · Multiple myeloma · NSCLC · Colorectal cancer
8 more
Pancreatic cancer · Patient-derived xenografts (PDX) · Cell line-derived xenografts (CDX) · Syngeneic mouse models · Humanized mouse models · Solid tumor models · Blood cancer models · Hematological cancer models
Industries served
- Biotech
- Pharma
- Oncology
Company
- Type
- CRO
- Founded
- 2007
- Quality
- GCLP (clinical flow cytometry services)
Locations
- Address
- 1330 Piccard Drive, Suite 025 & Suite 104 Rockville, MD 20850, USA
- Sites
- Hackensack, USA · Rockville, USA · Rehovot, Israel
- Serves
- global, U.S., globally, U.S.-based
Contacts
- Phone
- +1-240-907-2446
Similar labs
Work here? Claim this listing